Dennis Earle

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction

L E Diamond, Dennis Earle, R. Rosen et al. · International Journal of Impotence Research · 2004 · 127 citations

Urology, Erectile Dysfunction, Intranasal Pt-141 +6

An Effect on the Subjective Sexual Response in Premenopausal Women with Sexual Arousal Disorder by Bremelanotide (PT-141), a Melanocortin Receptor Agonist

Lisa E. Diamond, Dennis Earle, Julia R. Heiman et al. · The Journal of Sexual Medicine · 2006 · 113 citations

PT‐141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction

Perry B. Molinoff, A. M. Shadiack, Dennis Earle et al. · Annals of the New York Academy of Sciences · 2003 · 97 citations

Synthetic Peptide Analogue, Sexual Health, Urology +12

Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra®

R. Rosen, L E Diamond, Dennis Earle et al. · International Journal of Impotence Research · 2004 · 84 citations

Molecular Pharmacology, Therapeutic Drug Monitoring, Urology +9

Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response

L E Diamond, Dennis Earle, Wilson García et al. · Urology · 2005 · 44 citations

Urology, Erectile Dysfunction, Intranasal Pt-141 +5